This page is part of the Adverse Event Clinical Research R4 Backport (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
Generated Narrative: AdverseEvent
Resource AdverseEvent "adverse-event-compass-ex1a"
Profile: Adverse Event Clinical Research
Severity Or Grade: Severe (AdverseEvent Severity or Grade Codes#3)
Participant
url
function
value: authenticator (ParticipationType#AUTHEN)
url
actor
value: Practitioner/practitioner-owen-oncologist " ONCOLOGIST"
Suspect Entity
url
instance
value: MedicationAdministration/medication-administration-kadcyla
url
causality
Suspect Entity
url
instance
value: MedicationAdministration/medication-administration-tucatinib
url
causality
Expected In Research Study: true
Note: treatment held today per protocol guidelines and the patient was scheduled to return in one week for repeat lab work
modifierExtension[http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/status]
actuality: actual
event: Alanine aminotransferase (ALT) increased to 200 (www.meddra.org#10001551 "Alanine aminotransferase increased")
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
date: 2020-05-13
seriousness: Non-serious (AdverseEventSeriousness#non-serious)
outcome: Not recovering/not resolved (NCI Thesaurus#C49494)
recorder: Practitioner/practitioner-oncology-nurse-jane " NURSE"